Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$13,609,490
-$164,704 QoQ
Shares Held
53,587
-4.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#934
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $80,207,351 across 13 Drug Manufacturers - General names. JNJ ranks #3 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,358 | $19,466,367 | |
| 2 | LLY |
ELI LILLY & Co
|
15,030 | $18,027,434 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
53,587 | $13,609,490 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,604 | $10,229,114 | |
| 5 | AMGN |
Amgen Inc
|
14,339 | $5,192,438 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
40,890 | $5,166,042 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,891 | $3,047,579 | |
| 8 | PFE |
Pfizer Inc
|
103,774 | $2,498,877 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,609,490 | 53,587 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $13,774,194 | 56,350 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $10,948,068 | 52,902 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $9,889,561 | 53,336 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $6,656,081 | 43,575 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $7,197,290 | 43,399 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $6,181,203 | 42,741 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,897,273 | 42,560 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $7,753,524 | 49,014 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $8,317,408 | 53,065 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $15,743,521 | 101,082 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $9,318,113 | 56,296 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $8,116,885 | 52,367 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,197,812 | 52,068 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,277,124 | 50,668 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,902,659 | 50,153 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,128,367 | 40,221 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,365,418 | 43,055 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $6,820,306 | 42,231 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $6,800,631 | 41,281 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $5,944,868 | 36,172 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,382,238 | 34,199 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $3,912,715 | 26,281 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $2,574,654 | 18,308 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $2,543,659 | 19,398 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||